Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
2025-11-14 10:38:47 ET
Thesis
Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed in 2020 as a merger between Upjohn and Mylan – Sun Pharma, and Dr. Reddy’s ( RDY ), all of which have developed over several decades the capacity to leverage their size and manufacturing capabilities to claim a decent share of the market. These companies operate a kind of oligopoly in this niche space....
Read the full article on Seeking Alpha
For further details see:
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines BusinessNASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$37.83 Last:
113 Volume:
$37.83 Open:



